In this study, genes in PIK3/AKT/mTOR pathway were deciphered, and PIK3CA mutations were identified as the most frequent genetic alterations observed in 38% of Taiwanese patients with breast cancer. This evidence concerns the gene AKT1 and breast carcinoma.